| Literature DB >> 29618936 |
Ashgan Abdalla Alghobashy1, Usama M Alkholy1, Mohamed A Talat1, Nermin Abdalmonem1, Ahmed Zaki2, Ihab A Ahmed1, Randa H Mohamed3.
Abstract
BACKGROUND: The early imbalances of trace elements in type 1 diabetes (T1D) may cause disturbance of glucose metabolism and more oxidative stress that may enhance the development of insulin resistance and diabetic complications. We aim to evaluate the serum level of selenium (Se), zinc (Zn), magnesium (Mg), and copper (Cu), the degree of oxidative stress and evaluate their relations to glycemic control in children with T1D.Entities:
Keywords: oxidative stress; peroxidase; reduced glutathione; trace elements; type 1diabetes
Year: 2018 PMID: 29618936 PMCID: PMC5875397 DOI: 10.2147/DMSO.S157348
Source DB: PubMed Journal: Diabetes Metab Syndr Obes ISSN: 1178-7007 Impact factor: 3.168
Demographics, clinical, and routine laboratory data of the studied groups
| Variables | Diabetic group | Control group | ||
|---|---|---|---|---|
| Age (years), mean ± SD | 11.6 ± 2.9 | 11.4 ± 2.8 | 0.2 | 0.80 |
| BMI (kg/m2), mean ± SD | 18.5 ± 1.7 | 18.6 ± 0.7 | 0.1 | 0.90 |
| Sex: male/female | 50/50 | 18/22 | χ2/ 0.03 | 0.80 |
| Total cholesterol (mmol/L) | 4.1 ± 0.7 | 3.9 ± 0.5 | 0.2 | 0.056 |
| Triglycerides (mmol/L) | 1.2 ± 0.22 | 1.2 ± 0.18 | 0.22 | 0.066 |
| FPG (mmol/L) | 10.6 ± 2.5 | 4.8 ± 0.8 | 0.8 | <0.001 |
| Duration of illness (years), mean ± SD | 4.8 ± 2.6 (1–11) | – | ||
| Insulin dose(unit/kg), mean ± SD | 1.06 ± 0.2 (0.5–1.5) | – | ||
| Insulin type | – | |||
| Premix insulin | 55 (55%) | |||
| Basal bolus | 45 (45%) | |||
| Daily monitoring by RPG | ||||
| Once/day | 15 (15%) | – | ||
| Twice/day | 40 (40%) | |||
| Three times/day | 45 (45%) |
Note:
Highly significant.
Abbreviations: FPG, fasting plasma glucose; RPG, random plasma glucose.
Comparison between the diabetic and control groups in the laboratory investigations
| Variables | Diabetic group | Control group | ||
|---|---|---|---|---|
| A1c % mean ± SD | 8.6 ± 2.2 (6.5–12.2) | 5.1 ± 0.4 (4.5–6.0) | 9.3 | ≤ 0.001 |
| Cu (ug/dL) mean ± SD | 74.6 ± 9.2 (68.8–80.7) | 166.1 ± 38.5 (160–173.4) | 4 | ≤ 0.001 |
| Mg (mg/dL) mean ± SD | 1.96 ± 0.2 (1.5–2.5) | 2.2 ± 0.22 (1.9–3.5) | 2.8 | ≤ 0.05 |
| Zn (ug/dlL) mean ± SD | 103.3 ± 15.7 (94.4–115.6) | 129.6 ± 31.5 (115.6–140.3) | 2.00 | ≤ 0.05 |
| Se (ng/mL) mean ± SD | 16.1 ± 4 (7.6–27.7) | 33.7 ± 5.7 (22.8–41.05) | 9.5 | ≤ 0.001 |
| GSH (mg/gHb) mean ± SD | 1.69 ± 0.6 (0.8–2.8) | 2.74 ± 0.46 (2.0–3.6) | 7.0 | <0.001 |
| GPx (U/gHb) mean ± SD | 23.2 ± 6.4 (16.0–38.0) | 32.1 ± 4.4 (25.0–41.0) | 6.8 | <0.001 |
Note:
Significant;
Highly significant
Abbreviations: A1c %; glycosylated hemoglobin; Cu, copper; GPx, glutathione peroxidase; GSH, reduced glutathione; Mg, magnesium, Se, selenium; Zn, zinc.
Comparison between poor- and good-controlled diabetics regarding laboratory investigations
| Variable | Poor control | Good control | ||
|---|---|---|---|---|
| Cu (ug/dL) mean ± SD | 70.5 ± 8.2 (68.8–78.8) | 77.8 ± 9.2 (74.5–80.7) | 2.1 | <0.05 |
| Mg (mg/dL) mean ± SD | 1.88 ± 0.2 (1.5–1.99) | 2.03 ± 0.24 (1.7–2.5) | 5.9 | <0.001 |
| Zn (ug/dL) mean ± SD | 95.9 ± 2.4 (94.4–98.7) | 110.6 ± 17.7 (101.2–115.6) | 8.7 | <0.001 |
| Se (Ng/mL) mean ± SD | 15.6 ± 6.1 (7.6–26.4) | 24.7 ± 6.5 (20.5–27.6) | 5.1 | <0.001 |
| GSH (mg/gHb) mean ± SD | 1.35 ± 0.11 (0.8–2.0) | 2.5 ± 0.23 (2.4–2.8) | 6.8 | <0.001 |
| GPx (U/gHb) mean ± SD | 20.0 ± 3.8 (16.0–30.1) | 31.7 ± 4.6 (26.5–38) | 6.4 | <0.001 |
Note:
Significant;
Highly significant
Abbreviations: A1c %, glycosylated hemoglobin; Cu, copper; GPx, glutathione peroxidase; GSH, reduced glutathione; Mg, magnesium, Se, selenium; Zn, zinc.
Correlation between duration of illness, insulin dose and A1c % with other parameters of the diabetic group
| Variables | Duration of illness
| Insulin dose
| A1c %
| |||
|---|---|---|---|---|---|---|
| Age | 0.4 | >0.05 | 0.5 | <0.05 | 0.3 | >0.05 |
| BMI% | 0.03 | >0.05 | 0.1 | >0.05 | 0.1 | >0.05 |
| Insulin dose | 0.3 | 0.05 | – | – | 0.3 | >0.05 |
| Duration of illness | – | – | 0.3 | >0.05 | 0.7 | <0.001 |
| A1c % | 0.7 | <0.001 | 0.3 | >0.05 | – | – |
| Cu | –0.05 | >0.05 | 0.1 | >0.05 | –0.07 | >0.05 |
| Mg | –0.6 | <0.05 | −0.1 | >0.05 | –0.6 | < 0.001 |
| Zn | –0.2 | <0.05 | −0.07 | >0.05 | –0.5 | <0.05 |
| Se | –0.80 | <0.001 | −0.3 | >0.05 | –0.4 | <0.05 |
| GSH | –0.7 | <0.001 | 0.2 | >0.05 | –0.7 | <0.001 |
| GPx | –0.7 | <0.001 | 0.2 | >0.05 | –0.7 | <0.001 |
Note:
Significant;
Highly significant
Abbreviations: A1c %, glycosylated hemoglobin; Cu, copper; GPx, glutathione peroxidase; GSH, reduced glutathione; Mg, magnesium, Se, selenium; Zn, zinc.
Figure 1A correlation study between serum Se level and erythrocyte GSH and GPx.
Abbreviations: GPx, glutathione peroxidase; GSH, reduced glutathione.
Figure 2Scatter plots between A1c % and corresponding measurement serum Se, Cu, Zu, Mg, and erythrocyte GSH and GPx.
Abbreviations: A1c %, glycosylated hemoglobin; Cu, copper; GPx, glutathione peroxidase; GSH, reduced glutathione; HbA1c, hemoglobin A1c; Mg, magnesium, Se, selenium, Zn, zinc.